These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9337537

  • 21. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
    Au NH, Cheang M, Huntsman DG, Yorida E, Coldman A, Elliott WM, Bebb G, Flint J, English J, Gilks CB, Grimes HL.
    J Pathol; 2004 Sep; 204(1):101-9. PubMed ID: 15307143
    [Abstract] [Full Text] [Related]

  • 22. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.
    Sato T, Murakumo Y, Hagiwara S, Jijiwa M, Suzuki C, Yatabe Y, Takahashi M.
    Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683
    [Abstract] [Full Text] [Related]

  • 23. Simultaneous detection of intercellular adhesion molecule-1 (CD54) and carcinoembryonic antigen in lung adenocarcinoma.
    Nonomura A, Mizukami Y, Shimizu J, Hayashi Y, Murakami S, Watanabe Y, Kamimura R, Takashima T.
    Mod Pathol; 1994 Feb; 7(2):155-60. PubMed ID: 7911996
    [Abstract] [Full Text] [Related]

  • 24. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F, Aydiner A, Topuz E, Yasasever V, Karadeniz A, Saip P.
    J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
    [Abstract] [Full Text] [Related]

  • 25. [Tumor-associated markers in malignant lung neoplasms].
    Piancino G, Racca P, Rayneri W, Piantino P, Cerchier A, Pecchio F.
    Minerva Med; 1986 Jan 14; 77(1-2):19-25. PubMed ID: 3945411
    [Abstract] [Full Text] [Related]

  • 26. [Expression of tumor-associated antigen LEA and its significance for pathological diagnosis].
    Feng H, Song JD.
    Ai Zheng; 2002 Jun 14; 21(6):658-62. PubMed ID: 12452070
    [Abstract] [Full Text] [Related]

  • 27. Maintenance of morphology and tumour marker production in human epidermoid lung carcinoma xenografts.
    Bak M, Mattern J, Volm M.
    In Vivo; 1987 Jun 14; 1(5):319-26. PubMed ID: 2485134
    [Abstract] [Full Text] [Related]

  • 28. Relationship between N-linked oligosaccharide chains of human serum immunoglobulin G and serum tumor markers with non-small cell lung cancer progression.
    Kanoh Y, Ohara T, Mashiko T, Abe T, Masuda N, Akahoshi T.
    Anticancer Res; 2006 Jun 14; 26(6B):4293-7. PubMed ID: 17201147
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer.
    Nisman B, Amir G, Lafair J, Heching N, Lyass O, Peretz T, Barak V.
    Anticancer Res; 1999 Jun 14; 19(4C):3549-52. PubMed ID: 10629651
    [Abstract] [Full Text] [Related]

  • 34. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
    Ishikawa N, Takano A, Yasui W, Inai K, Nishimura H, Ito H, Miyagi Y, Nakayama H, Fujita M, Hosokawa M, Tsuchiya E, Kohno N, Nakamura Y, Daigo Y.
    Cancer Res; 2007 Dec 15; 67(24):11601-11. PubMed ID: 18089789
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Expression of heat shock proteins HSP70 and HSP27 in primary non-small cell lung carcinomas. An immunohistochemical study.
    Małusecka E, Zborek A, Krzyzowska-Gruca S, Krawczyk Z.
    Anticancer Res; 2001 Dec 15; 21(2A):1015-21. PubMed ID: 11396134
    [Abstract] [Full Text] [Related]

  • 37. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.
    Histopathology; 2009 Jun 15; 54(7):804-13. PubMed ID: 19635099
    [Abstract] [Full Text] [Related]

  • 38. Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases.
    Cassoni P, Daniele L, Maldi E, Righi L, Tavaglione V, Novello S, Volante M, Scagliotti GV, Papotti M.
    Histopathology; 2009 Jul 15; 55(1):20-7. PubMed ID: 19614763
    [Abstract] [Full Text] [Related]

  • 39. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.
    Ann Thorac Surg; 2005 Jan 15; 79(1):248-53. PubMed ID: 15620951
    [Abstract] [Full Text] [Related]

  • 40. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma.
    Tomita M, Matsuzaki Y, Edagawa M, Shimizu T, Hara M, Onitsuka T.
    Ann Thorac Cardiovasc Surg; 2004 Apr 15; 10(2):76-80. PubMed ID: 15209547
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.